Medscape Conference Coverage, based on selected sessions at the:

American Public Health Association (APHA) 135th Annual Meeting and Exposition

November 03 - 07, 2007; Washington, DC

This activity is not sanctioned by, nor a part of, the American Public Health Association.

Topic Overviews

Violent Death Associated With Specific HLA Haplotypes

Certain heterozygotes for HLA-A and HLA-B heterozygotes were significantly associated with increased incidence of violent death; for HLA-BW, homozygotes had a significantly increased odds ratio, whereas heterozygotes had a significantly reduced odds ratio for violent death.
Medscape Medical News, November 6, 2007

Conference News

Dating Violence Strikes Both Boys and Girls

Both boys and girls experience physical violence within their dating relationships; a separate study addressed adult men who experienced sexual assault.
Medscape Medical News, November 9, 2007
Multidrug-Resistant Tuberculosis Increasing in Texas

Asymptomatic carriers of tuberculosis are the most difficult cases to diagnose; better diagnostic tools are needed, a researcher says.
Medscape Medical News, November 9, 2007
APHA to Create Major Climate Change Initiative

The American Public Health Association is meeting with public health experts and policy makers to develop a series of practical recommendations that the public can adopt to help reduce the health effects of climate change.
Medscape Medical News, November 7, 2007
High Rate of PTSD in Returning Iraq War Veterans

A minimum of 300,000 psychiatric casualties are expected to result among the veterans who have served in Iraq to date, with an estimated lifetime treatment cost of $660 billion.
Medscape Medical News, November 6, 2007
Violent Death Associated With Specific HLA Haplotypes

Certain heterozygotes for HLA-A and HLA-B heterozygotes were significantly associated with increased incidence of violent death; for HLA-BW, homozygotes had a significantly increased odds ratio, whereas heterozygotes had a significantly reduced odds ratio for violent death.
Medscape Medical News, November 6, 2007

Disclaimer

The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.

The materials presented here were prepared by independent authors under the editorial supervision of Medscape and were developed in collaboration with the American Public Health Association.